AngioDynamics (ANGO) Tops Q2 EPS by 10c, Beats on Revenue; Offers Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $12.47 +0.65%
Revenue Growth %: +0.0%
Financial Fact:
Total operating expenses: 41.46M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +0.0%
Financial Fact:
Total operating expenses: 41.46M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.00, $0.10 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $79.4 million versus the consensus estimate of $76.3 million.
GUIDANCE:
AngioDynamics sees FY2026 EPS of ($0.33)-($0.23), versus the consensus of ($0.33). AngioDynamics sees FY2026 revenue of $312-314 million, versus the consensus of $310 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- BofA lists top 5 themes driving next $1tn in incremental semi sales
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
